Xenogen Marks Sample Clauses

The "Xenogen Marks" clause defines the ownership and permitted use of trademarks, logos, and other brand identifiers associated with Xenogen. Typically, this clause specifies that Xenogen retains all rights to its marks and outlines the conditions under which another party may use them, such as requiring prior written consent or restricting use to specific marketing materials. Its core function is to protect Xenogen's brand identity and intellectual property, ensuring that its marks are not misused or misrepresented by others.
Xenogen Marks. For PMS colors and sizing information, or for high resolution versions of Xenogen marks for 4-color printing, please contact ▇▇▇▇▇ ▇▇▇▇▇▇▇▇, Manager of Creative Services, Xenogen Corporation, ▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇., ▇▇▇▇▇▇▇, ▇▇▇▇▇. Phone ▇▇▇.▇▇▇.▇▇▇▇, e-mail: ▇▇▇▇▇.▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇ The following sets forth the range of Licensed Products that Distributor is entitled to resell and distribute, the Territory in which Distributor is entitled to resell and distribute those Licensed Products, the distributor discount that Xenogen will apply to its U.S. list price to result in the transfer price that Distributor will pay Xenogen for purchase of the Licensed Products for sale or distribution in the Territory; and the U.S. list price for such Licensed Products. • Instrumentation ▇▇▇▇™ 100 Series‡ $ 195,000 *** ▇▇▇▇™ 50 Series‡ $ 123,500 *** Work Station Complete XWC-360 $ 13,990 *** Living Image® Software‡ XLI-2.12 $ 499 *** Calibrated Light Source XLS-4 $ 975 *** Gas Anesthesia System XGI-8 $ 11,690 *** Anesthesia Manifold XAM-5 $ 346 *** Anesthesia Manifold Nose Cones (set of 5) XNC-2 $ 18 *** Manifold Dividers (set of 5) XMD-2 $ 8 *** Anesthesia Filter XAF-8 $ 24 *** System Cart XSC-1 $ 747 *** Work Station XWS-260 $ 2,951 *** Uninterruptible Power Supply (110V) XPS-110 $ 1,301 *** UPS external battery (110V) XEB-110 $ 798 *** Plate Positioner XPP-1 $ 349 *** Reflective Hemisphere XRH-2 $ 300 *** Black Paper XBP-24 $ 15 *** Animal Shield Kit XAS-3 $ 227 *** ▇▇▇▇™ Fluorescence Option (kit includes 1 pair of standard filters) XFO-6 $ 35,000 *** ‡ Indicates that either a Commercial or a Non-Commercial Imaging End-User Agreement is required (see Exhibits C-1 and C-2). *** Confidential treatment requested o Imaging Technology License Fee § Commercial Local Customer: *** of Xenogen’s net revenue from the license fee paid by the Commercial End User (see Exhibit C-1) to practice the Xenogen Imaging Technology. Xenogen’s minimum net revenue for each Imaging Technology license fee is *** per month for the first year of such license and *** per month thereafter. For purposes of this fee, “net revenue” means and refers to the amount payable to Xenogen after deduction of any applicable withholding taxes. § Non-Commercial Local Customer: Waived in consideration for stating the use of Xenogen Imaging Technology” and/or of ▇▇▇▇™ Imaging System (or named accessories)” in publications. • Biological Materials o Bioware™‡‡: *** for one (1) year evaluation fee (plus shipping). *** ini...
View SourceView Similar (2)

Related to Xenogen Marks

  • Service Marks BlueCross BlueShield of Western New York is an independent corporation organized under the New York Insurance Law. BlueCross BlueShield of Western New York also operates under licenses with the BlueCross BlueShield Association, which licenses BlueCross BlueShield of Western New York to use the BlueCross BlueShield service marks in a portion of New York State. BlueCross BlueShield of Western New York does not act as an agent of the BlueCross BlueShield Association. BlueCross BlueShield of Western New York is solely responsible for the obligations created under this agreement.

  • License for Txdot Logo Use DocuSign Envelope ID: 08011FCF-93C2-4F54-8A05-20A33047A1D8

  • Licensed Technology (a) LICENSOR is not aware of any interference, infringement, misappropriation, or other conflict with any intellectual property rights of third parties, and LICENSOR has never received any charge, complaint, claim, demand, or notice alleging any such interference, infringement, misappropriation, or violation (including any claim that LICENSOR must license or refrain from using any intellectual property rights of any third party). To the knowledge of LICENSOR, no third party has interfered with, infringed upon, misappropriated, or otherwise come into conflict with any of the LICENSED TECHNOLOGY. (b) Exhibit A identifies each patent or registration which has been issued to LICENSOR with respect to any of the LICENSED TECHNOLOGY and identifies each pending patent application or application for registration which LICENSOR has made with respect to any of the LICENSED TECHNOLOGY. LICENSEE acknowledges that LICENSOR has previously made available to LICENSEE correct and complete copies of all such patents, registrations and applications (as amended to-date) in LICENSOR’s possession and has made available to LICENSEE correct and complete copies of all other written documentation in LICENSOR’s possession evidencing ownership and prosecution (if applicable) of each such item. (c) Exhibit A identifies each item of LICENSED TECHNOLOGY that is assigned to LICENSOR or that LICENSOR uses pursuant to license, sublicense, agreement, or permission. LICENSOR has made available to LICENSEE correct and complete copies of all such licenses, sublicenses, agreements, patent prosecution files and permissions (as amended to-date) in LICENSOR’s possession. With respect to each item of LICENSED TECHNOLOGY required to be identified in Exhibit A and to the knowledge of LICENSOR: (i) the license, sublicense, agreement, or permission covering the item is legal, valid, binding, enforceable, and in full force and effect; (ii) the license, sublicense, agreement, or permission will continue to be legal, valid, binding, enforceable, and in full force and effect on identical terms following the consummation of the transactions contemplated hereby; (iii) no Party to the license, sublicense, agreement, or permission is in breach or default, and no event has occurred which with notice or lapse of time would constitute a breach or default or permit termination, modification, or acceleration thereunder; (iv) no party to the license, sublicense, agreement, or permission has repudiated any provision thereof; (v) the underlying item of LICENSED TECHNOLOGY is not subject to any outstanding lien or encumbrance, injunction, judgment, order, decree, ruling, or charge; (vi) no action, suit, proceeding, hearing, investigation, charge, complaint, claim, or demand is pending or is threatened which challenges the legality, validity, or enforceability of the underlying item of LICENSED TECHNOLOGY; and (vii) except as provided in Exhibit A, LICENSOR has not granted any license or similar right to the LICENSED TECHNOLOGY within the GENERAL FIELD or PARTHENOGENESIS FIELD.

  • Product Trademarks BMS shall be solely responsible for the selection (including the creation, searching and clearing), registration, maintenance, policing and enforcement of all trademarks developed for use in connection with the marketing, sale or distribution of Products in the Field in the Territory (the “Product Marks”). BMS shall own all Product Marks, and all trademark registrations for said marks.

  • Third Party Technology The Company makes use of third party technology to collect information required for traffic measurement, research, and analytics. Use of third party technology entails data collection. We therefore would like to inform clients the Company enables third parties to place or read cookies located on the browsers of users entering the Company’s domain. Said third parties may also use web beacons to collect information through advertising located on the Company’s web site. Please note that you may change your browser settings to refuse or disable Local Shared Objects and similar technologies; however, by doing so you may be disabling some of the functionality of Company’s services.